Kotak Manufacture In India Fund vs SBI Healthcare Opportunities Fund
Direct Plan, Growth option · Data as on 30-10-2026
Kotak Manufacture In India Fund is a Thematic fund and SBI Healthcare Opportunities Fund is a Thematic fund. In the 3 years to 30-10-2026, Kotak Manufacture In India Fund (Direct) returned 18.9% a year and SBI Healthcare Opportunities Fund (Direct) returned 24.6% a year. Kotak Manufacture In India Fund charges 0.76% a year and SBI Healthcare Opportunities Fund 1.01% (Direct plans). Their portfolios overlap 10.4%: they hold 4 of the same securities.
Kotak Manufacture In India Fund
Thematic
- 3 year return
- 18.9%
- Expense ratio
- 0.76%
- NAV
- ₹22.21
SBI Healthcare Opportunities Fund
Thematic
- 3 year return
- 24.6%
- Expense ratio
- 1.01%
- NAV
- ₹588.16
Which is better, Kotak Manufacture In India or SBI Healthcare Opportunities? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- SBI Healthcare Opportunities returned more over 3 years: 24.6% a year against 18.9%.
- SBI Healthcare Opportunities returned more over 1 year: 17.1% against 6.2%.
- Kotak Manufacture In India costs less: 0.76% a year against 1.01% (Direct plans).
- SBI Healthcare Opportunities swung less over 3 years: a standard deviation of 13.1% a year against 15.9%.
- SBI Healthcare Opportunities fell less in its worst fall since 02-03-2022: −14.4% against −22.3%.
- SBI Healthcare Opportunities is the larger fund: ₹5,870 Cr against ₹3,132 Cr.
- Their portfolios overlap 10.4%: 4 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | Kotak Manufacture In India Fund | SBI Healthcare Opportunities Fund |
|---|---|---|
| Fund house | Kotak Mahindra Mutual Fund | SBI Mutual Fund |
| Category | Thematic | Thematic |
| AUM | ₹3,132 Cr (30-09-2026) | ₹5,870 Cr (30-09-2026) |
| NAV | ₹22.21 (Direct) | ₹588.16 (Direct) |
| Expense ratio (Direct) | 0.76% | 1.01% |
| Expense ratio (Regular) | 2.08% | 1.99% |
| Riskometer | Very High | Not available |
| Benchmark | Nifty India Manufacturing TRI | Not available |
| Launch date | 22-02-2022 | Not available |
| Minimum investment | ₹100 | Not available |
| Lock in | None | Not available |
| Fund managers | Harsha Upadhyaya, Abhishek Bisen | Not available |
| Exit load | 0.5% for redemption within 90 Days | Not available |
Kotak Manufacture In India vs SBI Healthcare Opportunities: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| Kotak Manufacture In India Fund (Direct) | −5.87% | −3.37% | +3.31% | +6.20% | +18.88% | -- | -- |
| SBI Healthcare Opportunities Fund (Direct) | +0.31% | −0.59% | +16.00% | +17.12% | +24.60% | +19.22% | +14.72% |
| Thematic average | −2.09% | −4.52% | +0.86% | −1.22% | +13.76% | +11.62% | +13.76% |
Category average: the average of the 235 Thematic funds, same plan type.
Kotak Manufacture In India vs SBI Healthcare Opportunities: Year-wise Returns
| Year | Kotak Manufacture In IndiaKotak Manufacture In India | SBI Healthcare OpportunitiesSBI Healthcare Opportunities |
|---|---|---|
| 2026to date | +5.71% | +21.31% |
| 2025 | +9.02% | −2.50% |
| 2024 | +27.83% | +43.75% |
| 2023 | +34.40% | +39.72% |
| 2022 | -- | −5.01% |
| 2021 | -- | +21.48% |
Kotak Manufacture In India vs SBI Healthcare Opportunities: Rolling Returns
Every holding period of both funds, against Nifty India Manufacturing TRI, the benchmark of Kotak Manufacture In India Fund
Rolling returns
Every 3-year holding period, 409 of them, one for each trading day from 03-03-2025 to 30-10-2026: the yearly return (CAGR) of each, plotted on the day it ended. One lucky or unlucky start day cannot flatter or hide a fund.
Kotak Manufacture In India Fund (Direct)
SBI Healthcare Opportunities Fund (Direct)
Nifty India Manufacturing TRI
to
Apr 2025Aug 2022
to
Aug 2025Nov 2022
to
Nov 2025Feb 2023
to
Feb 2026Jun 2023
to
Jun 2026Sept 2023
to
Sept 2026
How the periods spread
| Fund | Below 0% | 0-5% | 5-10% | 10-15% | 15-20% | 20-25% | Above 25% | Mean | Median | Lowest | Highest | Beat benchmark |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kotak Manufacture In India | 0.0 | 0.0 | 0.0 | 0.0 | 13.7 | 81.9 | 4.4 | 21.9% | 21.9% | 16.0% | 26.1% | 33% |
| SBI Healthcare Opportunities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 32.3 | 67.7 | 26.1% | 25.6% | 21.4% | 31.1% | 100% |
| Nifty India Manufacturing TRI | 0.0 | 0.0 | 0.0 | 0.5 | 20.8 | 69.2 | 9.5 | 22.1% | 22.4% | 14.9% | 27.7% | -- |
The table shows the % of periods in each return band; a darker cell holds more of them. Lumpsum: the yearly rate (CAGR) from a period's first NAV to its last. SIP: the XIRR of the monthly instalments. The benchmark is Nifty India Manufacturing TRI, over the same periods. "Beat benchmark" counts the periods in which the fund did better. Every fund is measured over the days all of them have, from 02-03-2022. Past returns do not promise future returns.
Kotak Manufacture In India vs SBI Healthcare Opportunities: SIP and Lumpsum Returns
What the same monthly or one-time investment would be worth in each fund today, from their own NAV history
Growth of an investment
₹10,000 on the first trading day of every month, from 02-03-2022 to 30-10-2026: 56 instalments, ₹5,60,000 in all.
| Investment | Invested | Value now | Gain | Return a year |
|---|---|---|---|---|
| Kotak Manufacture In IndiaKotak Manufacture In India Fund (Direct) | ₹5,60,000 | ₹8,12,953 | ₹2,52,953 | 16.1% |
| SBI Healthcare OpportunitiesSBI Healthcare Opportunities Fund (Direct) | ₹5,60,000 | ₹9,32,194 | ₹3,72,194 | 22.1% |
Kotak Manufacture In IndiaKotak Manufacture In India Fund (Direct)
SBI Healthcare OpportunitiesSBI Healthcare Opportunities Fund (Direct)
Amount invested
From each plan's published NAV (Growth option), over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.
Kotak Manufacture In India vs SBI Healthcare Opportunities: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | Kotak Manufacture In India Fund (Direct) | SBI Healthcare Opportunities Fund (Direct) |
|---|---|---|
| Return (CAGR) | +6.20% | +17.12% |
| Standard deviation | 15.82% | 13.36% |
| Sharpe ratio | 0.06 | 0.89 |
| Sortino ratio | 0.08 | 1.33 |
| Maximum drawdown | −11.6% (23-03-2026) | −10.3% (23-10-2026) |
| Beta | 0.96 | 0.93 |
| Alpha | +7.63% | +5.25% |
From daily NAVs, 30-10-2025 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | Kotak Manufacture In India Fund (Direct) | SBI Healthcare Opportunities Fund (Direct) |
|---|---|---|
| Return (CAGR) | +18.88% | +24.60% |
| Standard deviation | 15.92% | 13.07% |
| Sharpe ratio | 0.81 | 1.42 |
| Sortino ratio | 1.09 | 2.03 |
| Maximum drawdown | −22.3% (28-02-2025) | −13.5% (28-02-2025) |
| Beta | 0.97 | 0.88 |
| Alpha | +2.09% | +3.61% |
From daily NAVs, 30-10-2023 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | Kotak Manufacture In India Fund (Direct) | SBI Healthcare Opportunities Fund (Direct) |
|---|---|---|
| Return (CAGR) | +18.64% | +17.93% |
| Standard deviation | 14.54% | 15.96% |
| Sharpe ratio | 0.87 | 0.74 |
| Sortino ratio | 1.18 | 1.05 |
| Maximum drawdown | −22.3% (28-02-2025) | −30.5% (23-03-2020) |
| Beta | 0.93 | 0.91 |
| Alpha | +3.05% | +3.97% |
From daily NAVs, 02-03-2022 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
Kotak Manufacture In India Fund (Direct)
SBI Healthcare Opportunities Fund (Direct)
Nifty India Manufacturing TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| Kotak Manufacture In India Fund (Direct) | −22.3% | 27-09-2024 | 28-02-2025 | 18-09-2025 | 7 months | −8.5% |
| SBI Healthcare Opportunities Fund (Direct) | −14.4% | 21-04-2022 | 17-06-2022 | 01-11-2022 | 5 months | −3.8% |
| Nifty India Manufacturing TRI | −23.0% | 27-09-2024 | 07-04-2025 | 05-01-2026 | 9 months | −10.5% |
From daily values since 02-03-2022, the first day every fund has.
Rolling standard deviation
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 1-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
Kotak Manufacture In India Fund (Direct)
SBI Healthcare Opportunities Fund (Direct)
Nifty India Manufacturing TRI
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 3-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
Kotak Manufacture In India Fund (Direct)
SBI Healthcare Opportunities Fund (Direct)
Nifty India Manufacturing TRI
Against Nifty India Manufacturing TRI
| Fund | Up capture | Down capture | Tracking error |
|---|---|---|---|
| Kotak Manufacture In India Fund (Direct) | 97% | 81% | 5.17% |
| SBI Healthcare Opportunities Fund (Direct) | 87% | 47% | 12.20% |
From month-end values since 02-03-2022. Up capture: a fund's average month when the benchmark rose, as % of the benchmark's; above 100% it gained more. Down capture: the same for months the benchmark fell; below 100% it fell less. Tracking error: how far the monthly returns strayed from the benchmark's, a year; an index fund aims near 0.
Kotak Manufacture In India vs SBI Healthcare Opportunities: Portfolio Overlap
From each fund's latest monthly portfolio: Kotak Manufacture In India Fund, September 2026; SBI Healthcare Opportunities Fund, September 2026
Holdings in common
- Overlap
- 10.4%
- Held by both
- 4
- Only in Kotak Manufacture In India
- 56
- Only in SBI Healthcare Opportunities
- 32
| Security | % of Kotak Manufacture In India | % of SBI Healthcare Opportunities |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | 4.35% | 11.14% |
| Divis Laboratories Ltd. | 3.71% | 7.91% |
| ANTHEM BIOSCIENCES LTD | 1.18% | 2.75% |
| BIOCON LTD. | 1.18% | 2.37% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 10.4% means 10.4% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in Kotak Manufacture In India Fund
| Security | % of fund |
|---|---|
| RUBICON RESEARCH LIMITED | 4.31% |
| Mahindra & Mahindra Ltd. | 3.53% |
| Tata Steel Ltd. | 3.41% |
| TVS Motor Company Ltd. | 3.28% |
| INDO-MIM LTD | 3.27% |
Largest holdings only in SBI Healthcare Opportunities Fund
| Security | % of fund |
|---|---|
| Acutaas Chemicals Ltd. | 5.03% |
| Apollo Hospitals Enterprise Ltd. | 4.45% |
| Torrent Pharmaceuticals Ltd. | 4.42% |
| Cipla Ltd. | 4.40% |
| Laurus Labs Ltd. | 4.05% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | Kotak Manufacture In India | SBI Healthcare Opportunities |
|---|---|---|
| Equity | 95.9% | 95.5% |
| Debt | 0.0% | 0.1% |
| Cash and others | 4.1% | 4.4% |
Market cap of stocks
| Market cap | Kotak Manufacture In India | SBI Healthcare Opportunities |
|---|---|---|
| Large Cap | 38.6% | 32.3% |
| Mid Cap | 18.6% | 25.7% |
| Small Cap | 31.1% | 35.4% |
| Not on AMFI's list | 7.5% | 2.2% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | Kotak Manufacture In India | SBI Healthcare Opportunities |
|---|---|---|
| Pharmaceuticals & Biotechnology | 0.0% | 63.1% |
| Healthcare Services | 0.0% | 25.6% |
| Pharmaceuticals and Biotechnology | 17.8% | 0.0% |
| Automobiles | 13.7% | 0.0% |
| Industrial Manufacturing | 11.0% | 0.0% |
| Industrial Products | 7.9% | 0.0% |
| Auto Components | 6.4% | 0.0% |
| Aerospace and Defense | 5.7% | 0.0% |
| Chemicals & Petrochemicals | 0.0% | 5.0% |
| Healthcare Equipment & Supplies | 0.0% | 1.8% |
The six largest sectors of each fund's stocks, % of the fund.
Kotak Manufacture In India vs SBI Healthcare Opportunities: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | Kotak Manufacture In India Fund | SBI Healthcare Opportunities Fund |
|---|---|---|
| Total expense ratio (Direct) | 0.76% | 1.01% |
| Base expense ratio (Direct) | 0.56% | 0.74% |
| Total expense ratio (Regular) | 2.08% | 1.99% |
| Base expense ratio (Regular) | 1.67% | 1.58% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare Kotak Manufacture In India with
Kotak Manufacture In India Fund vs SBI Healthcare Opportunities Fund: Frequently Asked Questions
What is the difference between Kotak Manufacture In India Fund and SBI Healthcare Opportunities Fund?
Kotak Manufacture In India Fund is a Thematic fund, SBI Healthcare Opportunities Fund is a Thematic fund, run by Kotak Mahindra Mutual Fund and SBI Mutual Fund. Their portfolios overlap 10.4%. Kotak Manufacture In India Fund charges 0.76% a year and SBI Healthcare Opportunities Fund 1.01%.
Which has given higher returns, Kotak Manufacture In India Fund or SBI Healthcare Opportunities Fund?
Over 1 year: Kotak Manufacture In India Fund +6.20%, SBI Healthcare Opportunities Fund +17.12%. Over 3 years: Kotak Manufacture In India Fund +18.88% a year, SBI Healthcare Opportunities Fund +24.60% a year. As on 30-10-2026. Past returns do not promise future returns.
Which has the lower expense ratio, Kotak Manufacture In India Fund or SBI Healthcare Opportunities Fund?
Kotak Manufacture In India Fund charges less: 0.76% a year against 1.01%. These are the Direct plans' total expense ratios reported to AMFI.
How much do Kotak Manufacture In India Fund and SBI Healthcare Opportunities Fund overlap?
10.4%. They hold 4 of the same securities, the largest shared ones being SUNPHARMA, DIVISLAB, ANTHEM. From each fund's latest monthly portfolio.
Which is better for SIP, Kotak Manufacture In India Fund or SBI Healthcare Opportunities Fund?
Over the last 3 years, a monthly SIP of ₹10,000 from 03-10-2023 to 30-10-2026 grew to ₹4,38,835 in Kotak Manufacture In India Fund (XIRR 11.1% a year) and ₹4,84,796 in SBI Healthcare Opportunities Fund (XIRR 17.9% a year). Both received 37 instalments. Past returns do not promise future returns.
Can I invest in both Kotak Manufacture In India Fund and SBI Healthcare Opportunities Fund?
Yes. 10.4% of each fund's money sits in the same holdings, so some of the two investments would move together.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.